lomerizine has been researched along with dizocilpine maleate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chavko, M; Danielisová, V | 1 |
| Akaike, A; Hara, H; Honda, Y; Kashii, S; Shimazawa, M; Toriu, N; Yasuyoshi, H; Zhang, S | 1 |
2 other study(ies) available for lomerizine and dizocilpine maleate
| Article | Year |
|---|---|
Comparative effects of the N-methyl-D-aspartate antagonist MK-801 and the calcium channel blocker KB-2796 on neurologic and metabolic recovery after spinal cord ischemia.
Topics: Adenosine Triphosphate; Animals; Calcium Channel Blockers; Dizocilpine Maleate; Energy Metabolism; Excitatory Amino Acid Antagonists; Hindlimb; Ischemia; Lactic Acid; N-Methylaspartate; Piperazines; Rabbits; Reperfusion; Spinal Cord | 1998 |
Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina.
Topics: Animals; Calcium Channel Blockers; Cells, Cultured; Dizocilpine Maleate; Dose-Response Relationship, Drug; Flunarizine; Glutamic Acid; Male; Neuroprotective Agents; Neurotoxicity Syndromes; Piperazines; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 2000 |